ImageneBio Inc
IMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $9 | $16 | $31 |
| % Growth | -61.8% | -41.3% | -49.6% | – |
| Cost of Goods Sold | $0 | $1 | $64 | $47 |
| Gross Profit | $4 | $8 | -$49 | -$16 |
| % Margin | 100% | 88.9% | -311.8% | -52% |
| R&D Expenses | $32 | $60 | $64 | $47 |
| G&A Expenses | $8 | $25 | $22 | $18 |
| SG&A Expenses | $8 | $25 | $22 | $18 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1 | -$64 | -$47 |
| Operating Expenses | $41 | $84 | $22 | $18 |
| Operating Income | -$37 | -$75 | -$71 | -$34 |
| % Margin | -1,057.1% | -823.3% | -454% | -110.2% |
| Other Income/Exp. Net | $0 | $7 | $2 | $0 |
| Pre-Tax Income | -$37 | -$68 | -$69 | -$34 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$37 | -$68 | -$69 | -$34 |
| % Margin | -1,044.8% | -744.2% | -440.3% | -110.1% |
| EPS | -1.02 | -1.63 | -1.9 | -0.95 |
| % Growth | 37.4% | 14.2% | -100% | – |
| EPS Diluted | -1.02 | -1.63 | -1.9 | -0.95 |
| Weighted Avg Shares Out | 48 | 42 | 36 | 36 |
| Weighted Avg Shares Out Dil | 48 | 42 | 36 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $7 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $1 | $1 | $1 |
| EBITDA | -$35 | -$74 | -$70 | -$34 |
| % Margin | -1,013.5% | -812.2% | -449.2% | -108.4% |